Shanghai, China

Xingwu Zhu

This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignees: Shanghai Aryl Pharmtech Co., Ltd., Zhejiang Hisun Pharmaceutical Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xingwu Zhu. Retrieved from https://idiyas.com/inventor/xingwu-zhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Xingwu Zhu

Introduction

Xingwu Zhu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on macrolide derivatives. His research and inventions have the potential to impact the treatment of various diseases.

Latest Patents

Xingwu Zhu holds a patent for macrolide derivatives, which includes a preparation method and its application as an inhibitor of specific protein kinases such as TRK, ALK, and ROS1. This patent represents a significant advancement in the development of therapeutic agents.

Career Highlights

Throughout his career, Xingwu Zhu has worked with prominent companies in the pharmaceutical industry. He has been associated with Zhejiang Hisun Pharmaceutical Co., Ltd. and Shanghai Aryl Pharmtech Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Xingwu Zhu has collaborated with several professionals in his field, including Youxi Chen and Liang Gong. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Xingwu Zhu's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…